As of March 2024 Prometheus Biosciences has a market cap of $9.55 Billion. This makes Prometheus Biosciences the world's 1693th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $9.55 B | 0% |
2023 | $9.55 B | 86.92% |
2022 | $5.11 B | 232.13% |
2021 | $1.53 B |
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Epizyme EPZM | $0.24 B | -97.41% | ๐บ๐ธ USA |
Akebia Therapeutics AKBA | $0.38 B | -95.99% | ๐บ๐ธ USA |
Agenus
AGEN | $0.24 B | -97.46% | ๐บ๐ธ USA |